SpyGlass Pharma, Inc. (SGP)
Nasdaq: SGP · Surgical & Medical Instruments & Apparatus · Aliso Viejo, CA · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 26, 2026 | · |
| Research and development | 29,183 | 19,984 |
| General and administrative | 12,266 | 7,080 |
| Total operating expenses | 41,449 | 27,064 |
| Operating income | -41,449 | -27,064 |
| Interest and investment income | 3,106 | 1,317 |
| Total non-operating income (expense) | 1,580 | -2,100 |
| Income before income taxes | -39,869 | -29,164 |
| Income tax expense | 0 | 0 |
| Net income | -39,869 | -29,164 |
| Earnings per share, basic | -17.98 | -16.31 |
| Earnings per share, diluted | -17.98 | -16.31 |
| Weighted average shares, basic | 2,217,104 | 1,788,211 |
| Weighted average shares, diluted | 2,217,104 | 1,788,211 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding